Langstraat CL - Search Results

1

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.

Zivanovic O, Chi DS, Zhou Q, Iasonos A, Konner JA, Makker V, Grisham RN, Brown AK, Nerenstone S, Diaz JP, Schroeder ED, Langstraat CL, Paroder V, Lakhman Y, Soldan K, Su K, Gardner GJ, Andikyan V, Guo J, Jewell EL, Long Roche K, Troso-Sandoval T, Lichtman SM, Moukarzel LA, Dessources K, Abu-Rustum NR, Aghajanian C, Tew WP, Beumer J, Sonoda Y, O'Cearbhaill RE. Zivanovic O, et al. Among authors: langstraat cl. J Clin Oncol. 2021 Aug 10;39(23):2594-2604. doi: 10.1200/JCO.21.00605. Epub 2021 May 21. J Clin Oncol. 2021. PMID: 34019431 Free PMC article. Clinical Trial.

2

Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.

Allensworth SK, Langstraat CL, Martin JR, Lemens MA, McGree ME, Weaver AL, Dowdy SC, Podratz KC, Bakkum-Gamez JN. Allensworth SK, et al. Among authors: langstraat cl. Gynecol Oncol. 2013 Sep;130(3):499-504. doi: 10.1016/j.ygyno.2013.05.038. Epub 2013 Jun 5. Gynecol Oncol. 2013. PMID: 23747328 Free PMC article.

3

Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer.

AlHilli M, Langstraat C, Tran C, Martin J, Weaver A, McGree M, Mariani A, Cliby W, Bakkum-Gamez J. AlHilli M, et al. Int J Gynecol Cancer. 2015 Feb;25(2):193-202. doi: 10.1097/IGC.0000000000000339. Int J Gynecol Cancer. 2015. PMID: 25611896 Free PMC article.

4

Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.

Gill SE, McGree ME, Weaver AL, Cliby WA, Langstraat CL. Gill SE, et al. Among authors: langstraat cl. Gynecol Oncol. 2017 Feb;144(2):266-273. doi: 10.1016/j.ygyno.2016.11.021. Epub 2016 Dec 1. Gynecol Oncol. 2017. PMID: 27916269

5

Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible.

Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Wallace S, et al. Gynecol Oncol. 2017 Apr;145(1):21-26. doi: 10.1016/j.ygyno.2017.01.029. Epub 2017 Jan 31. Gynecol Oncol. 2017. PMID: 28159407

6

Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer.

Narasimhulu DM, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Narasimhulu DM, et al. Among authors: langstraat cl. Gynecol Oncol. 2019 Oct;155(1):58-62. doi: 10.1016/j.ygyno.2019.08.004. Epub 2019 Aug 8. Gynecol Oncol. 2019. PMID: 31402165

7

Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management.

Narasimhulu DM, Kumar A, Weaver AL, Langstraat CL, Cliby WA. Narasimhulu DM, et al. Among authors: langstraat cl. Gynecol Oncol. 2020 Jun;157(3):572-577. doi: 10.1016/j.ygyno.2020.03.024. Epub 2020 Apr 1. Gynecol Oncol. 2020. PMID: 32247602 Free PMC article.

8

Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer.

Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, Langstraat CL, Block MS, Kumar A. Narasimhulu DM, et al. Among authors: langstraat cl. Gynecol Oncol. 2020 Sep;158(3):646-652. doi: 10.1016/j.ygyno.2020.05.046. Epub 2020 Jun 6. Gynecol Oncol. 2020. PMID: 32518016

9

Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.

Plett H, Filippova OT, Garbi A, Kommoss S, Rosendahl M, Langstraat C, Phadnis S, Muallem MZ, Baert T, Chi DS, Aletti GD, Taran FA, Ramspott JP, Zivanovic O, du Bois A, Sonoda Y, Gardner G, Traut A, Roche KL, Harter P. Plett H, et al. Gynecol Oncol. 2020 Nov;159(2):434-441. doi: 10.1016/j.ygyno.2020.08.028. Epub 2020 Sep 9. Gynecol Oncol. 2020. PMID: 32919778 Free PMC article.

10

Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.

Fadadu PP, Polen-De CL, McGree ME, Weaver AL, Moynagh MR, Takahashi N, Langstraat CL, Cliby WA, Kumar A. Fadadu PP, et al. Among authors: langstraat cl. Gynecol Oncol. 2021 Jan;160(1):40-44. doi: 10.1016/j.ygyno.2020.10.025. Epub 2020 Oct 24. Gynecol Oncol. 2021. PMID: 33109391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page